These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1333012)

  • 21. Pharmacological profile of a novel, orally active leukotriene B4 antagonist, SM-15178.
    Ohmi N; Tani C; Yamada K; Fukui M
    Inflammation; 1994 Apr; 18(2):129-40. PubMed ID: 8070898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel molecules that antagonize leukotriene B4 binding to neutrophils.
    Lin AH; Morris J; Wishka DG; Gorman RR
    Ann N Y Acad Sci; 1988; 524():196-200. PubMed ID: 2837955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The preclinical pharmacological profile of the potent and selective leukotriene B4 antagonist CP-195543.
    Showell HJ; Conklyn MJ; Alpert R; Hingorani GP; Wright KF; Smith MA; Stam E; Salter ED; Scampoli DN; Meltzer S; Reiter LA; Koch K; Piscopio AD; Cortina SR; Lopez-Anaya A; Pettipher ER; Milici AJ; Griffiths RJ
    J Pharmacol Exp Ther; 1998 Jun; 285(3):946-54. PubMed ID: 9618393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-activity relationships study of two series of leukotriene B4 antagonists: novel indolyl and naphthyl compounds substituted with a 2-[methyl(2-phenethyl)amino]-2-oxoethyl side chain.
    Chan WK; Huang FC; Morrissette MM; Warus JD; Moriarty KJ; Galemmo RA; Dankulich WD; Poli G; Sutherland CA
    J Med Chem; 1996 Sep; 39(19):3756-68. PubMed ID: 8809164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis.
    Griffiths RJ; Pettipher ER; Koch K; Farrell CA; Breslow R; Conklyn MJ; Smith MA; Hackman BC; Wimberly DJ; Milici AJ
    Proc Natl Acad Sci U S A; 1995 Jan; 92(2):517-21. PubMed ID: 7831322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of ligand binding to leukotriene B4 receptors on guinea pig lung membranes by sulfhydryl modifying reagents.
    Falcone RC; Aharony D
    J Pharmacol Exp Ther; 1990 Nov; 255(2):565-71. PubMed ID: 2173748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel series of [2-[methyl(2-phenethyl)amino]-2-oxoethyl] benzene-containing leukotriene B4 antagonists: initial structure-activity relationships.
    Huang FC; Chan WK; Moriarty KJ; Poli G; Morrissette MM; Galemmo RA; Warus JD; Dankulich WP; Sutherland CA
    J Med Chem; 1996 Sep; 39(19):3748-55. PubMed ID: 8809163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of two leukotriene B4 (LTB4) receptor antagonists (LY255283 and SC-41930) on LTB4-induced human neutrophil adhesion and superoxide production.
    Schultz RM; Marder P; Spaethe SM; Herron DK; Sofia MJ
    Prostaglandins Leukot Essent Fatty Acids; 1991 Aug; 43(4):267-71. PubMed ID: 1658812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [3H]leukotriene B4 binding to the guinea-pig spleen membrane preparation: a rich tissue source for a high-affinity leukotriene B4 receptor site.
    Cheng JB; Cheng EI; Kohi F; Townley RG
    J Pharmacol Exp Ther; 1986 Jan; 236(1):126-32. PubMed ID: 3001280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-[(arylmethoxy)phenyl] carboxylic acids, hydroxamic acids, tetrazoles, and sulfonyl carboxamides. Potent orally active leukotriene D4 antagonists of novel structure.
    Musser JH; Kreft AF; Bender RH; Kubrak DM; Grimes D; Carlson RP; Hand JM; Chang J
    J Med Chem; 1990 Jan; 33(1):240-5. PubMed ID: 2104935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a novel series of (2-quinolinylmethoxy)phenyl-containing compounds as high-affinity leukotriene receptor antagonists. 1. Initial structure-activity relationships.
    Youssefyeh RD; Magnien E; Lee TD; Chan WK; Lin CJ; Galemmo RA; Johnson WH; Tan J; Campbell HF; Huang FC
    J Med Chem; 1990 Apr; 33(4):1186-94. PubMed ID: 2157009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional properties of guinea pig eosinophil leukotriene B4 receptor.
    Ng CF; Sun FF; Taylor BM; Wolin MS; Wong PY
    J Immunol; 1991 Nov; 147(9):3096-103. PubMed ID: 1655904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of antagonist and agonist binding to the leukotriene B4 receptor intact human polymorphonuclear neutrophils (PMN).
    Jackson RH; Morrissey MM; Sills MA; Jarvis MF
    J Pharmacol Exp Ther; 1992 Jul; 262(1):80-9. PubMed ID: 1320692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Affinity labeling of the membrane protein-binding component of human polymorphonuclear leukocyte receptors for leukotriene B4.
    Goldman DW; Gifford LA; Young RN; Marotti T; Cheung MK; Goetzl EJ
    J Immunol; 1991 Apr; 146(8):2671-7. PubMed ID: 1849936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. (+)-1-(3S,4R)-[3-(4-phenylbenzyl)-4-hydroxychroman-7-yl]cyclopentane carboxylic acid, a highly potent, selective leukotriene B4 antagonist with oral activity in the murine collagen-induced arthritis model.
    Koch K; Melvin LS; Reiter LA; Biggers MS; Showell HJ; Griffiths RJ; Pettipher ER; Cheng JB; Milici AJ; Breslow R
    J Med Chem; 1994 Sep; 37(20):3197-9. PubMed ID: 7932545
    [No Abstract]   [Full Text] [Related]  

  • 36. The leukotriene B4 receptor agonist/antagonist activities of SC-45694 in human neutrophils.
    Tsai BS; Keith RH; Villani-Price D; Haack RA; Djuric SW
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1493-8. PubMed ID: 8138959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis, and pharmacological evaluation of potent xanthone dicarboxylic acid leukotriene B4 receptor antagonists.
    Jackson WT; Boyd RJ; Froelich LL; Gapinski DM; Mallett BE; Sawyer JS
    J Med Chem; 1993 Jun; 36(12):1726-34. PubMed ID: 8389876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the leukotriene B4 receptor antagonist SC-41930 on colonic inflammation in rat, guinea pig and rabbit.
    Fretland DJ; Widomski D; Tsai BS; Zemaitis JM; Levin S; Djuric SW; Shone RL; Gaginella TS
    J Pharmacol Exp Ther; 1990 Nov; 255(2):572-6. PubMed ID: 2173749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leukotriene receptor antagonists. III. Pharmacological and chemical studies with LY137617, a leukotriene D4 and leukotriene E4 receptor antagonist.
    Herron DK; Whitesitt CA; Mallet BE; Rinkema LE; Haisch KD; Fleisch JH
    Drugs Exp Clin Res; 1988; 14(5):303-10. PubMed ID: 2851426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leukotriene B4 induces formation of inositol phosphates in rat peritoneal polymorphonuclear leukocytes.
    Mong S; Chi-Rosso G; Miller J; Hoffman K; Razgaitis KA; Bender P; Crooke ST
    Mol Pharmacol; 1986 Sep; 30(3):235-42. PubMed ID: 3018480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.